February 19, 2025
Medtronic has issued an “Urgent Medical Device Correction” about the accuracy of insulin pump delivery during changes in air pressure, such as airplane takeoffs and landings. […]
February 19, 2025
Despite recent legislation capping insulin prices and manufacturer assistance programs, some people with diabetes who require insulin still encounter barriers to obtaining a reliable supply. T1 […]
February 19, 2025
(Reuters) – About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, clinical trial experts and doctors say they may […]
February 19, 2025
TOPLINE: A comparison of morning and evening growth hormone injection schedules in children with growth disorders showed no significant differences in sleep-wake patterns, sleep duration, or […]
February 18, 2025
Many celebrities are talking enthusiastically about their experiences with weight-loss drugs — especially semaglutide-based glucagon-like peptide 1 receptor agonists (GLP-1 RAs; Ozempic, Wegovy). It’s no surprise […]
February 18, 2025
The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog (insulin aspart), for treating adults and children with diabetes. The […]
February 14, 2025
TOPLINE: In older patients with type 2 diabetes (T2D), the use of sodium-glucose cotransporter 2 (SGLT2) inhibitors is associated with increased cardiovascular benefits but reduced glycemic […]
February 14, 2025
The incidence of thyroid cancer in the United States, having plateaued in 2009 after a decades-long increase, has remained stable since then, despite efforts to control […]
February 14, 2025
The Obesity Working Group of the Spanish Society of Endocrinology and Nutrition (GOSEEN) conducts various awareness campaigns to address the growing global and national health challenges […]